References
- Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006;6:203–14.
- Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004;64:145–60.
- Akaike T, Maeda H. Nitric oxide and virus infection. Immunology 2000;101:300–8.
- Burgner D, Rockett K, Kwiatkowski D. Nitric oxide and infectious diseases. Arch Dis Child 1999;81:185–8.
- Nathan C. Natural resistance and nitric oxide. Cell 1995;82:873–6.
- Hollenberg SM, Cinel I. Bench-to-bedside review: Nitric oxide in critical illness—update 2008. Crit Care 2009;13:218.
- Reiss CS, Komatsu T. Does nitric oxide play a critical role in viral infections? J Virol 1998;72:4547–51.
- Simon M, Falk KI, Lundkvist A, Mirazimi A. Exogenous nitric oxide inhibits Crimean-Congo hemorrhagic fever virus. Virus Res 2006;120:184–90.
- Schnittler HJ, Feldmann H. Viral hemorrhagic fever—a vascular disease? Thromb Haemost 2003;89:967–72.
- Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, . Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 1997;121:839–46.
- Weber F, Mirazimi A. Interferon and cytokine responses to Crimean-Congo hemorrhagic fever virus: an emerging and neglected viral zonoosis. Cytokine Growth Fact Rev 2008;19:395–404.
- Doganci L. New insights on the bleeding disorders in CCHF. J Infect 2007;55:379–81.
- Sonmez M, Aydin K, Durmus A, Sucu N, Yilmaz M, Akdogan E, . Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever. J Infect 2007;55:184–7.
- Peters CJ, Zaki SR. Role of endothelium in viral hemorrhagic fevers. Crit Care Med 2002;30:268–73.
- Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-a in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006;193:941–4.
- Schurman L, Sedlinsky C, Mangano A, Sen L, Leiderman S, Fernandez G, . Estrogenic status influences nitric oxide regulated TNF-alpha release from human peripheral blood monocytes. Exp Clin Endocrinol Diabetes 2001;109:340–4.
- Naseem KM, Riba R. Unresolved roles of platelet nitric oxide synthase. J Thromb Haemost 2008;6:10–9.
- Valero N, Espina LM, Anez G, Torres E, Mosquera JA. Short report: Increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg 2002;66:762–4.
- Chaturvedi UC, Nagar R. Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance? FEMS Immunol Med Microbiol 2009;56:9–24.
- Ubol S, Chareonsirisuthigul T, Kasisith J, Klungthong C. Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology 2008;376:290–6.